ARMD10
MCID: MCL030
MIFTS: 22

Macular Degeneration, Age-Related, 10 (ARMD10)

Categories: Blood diseases, Eye diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Macular Degeneration, Age-Related, 10

MalaCards integrated aliases for Macular Degeneration, Age-Related, 10:

Name: Macular Degeneration, Age-Related, 10 57 74 13 72
Armd10 57 12 74
Macular Degeneration, Age-Related, Type 10 40
Age Related Macular Degeneration 10 12
Age-Related Macular Degeneration 10 29

Classifications:



External Ids:

Disease Ontology 12 DOID:0110022
MeSH 44 D008268
MedGen 42 C1969108
UMLS 72 C1969108

Summaries for Macular Degeneration, Age-Related, 10

UniProtKB/Swiss-Prot : 74 Macular degeneration, age-related, 10: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.

MalaCards based summary : Macular Degeneration, Age-Related, 10, also known as armd10, is related to macular degeneration, age-related, 1 and eye disease. An important gene associated with Macular Degeneration, Age-Related, 10 is ARMD10 (Macular Degeneration, Age-Related, 10). The drugs Bevacizumab and Angiogenesis Inhibitors have been mentioned in the context of this disorder. Affiliated tissues include eye and endothelial.

Disease Ontology : 12 An age related macular degeneration associated with variation in the genomic region 9:112,100,000-127,500,000 (GRCh38). TLR4 has been put forth as a candidate gene.

More information from OMIM: 611488 PS603075

Related Diseases for Macular Degeneration, Age-Related, 10

Symptoms & Phenotypes for Macular Degeneration, Age-Related, 10

Clinical features from OMIM:

611488

Drugs & Therapeutics for Macular Degeneration, Age-Related, 10

Drugs for Macular Degeneration, Age-Related, 10 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 8)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 4 216974-75-3
2 Angiogenesis Inhibitors Phase 4
3 Mitogens Phase 4
4 Angiogenesis Modulating Agents Phase 4
5 Antineoplastic Agents, Immunological Phase 4
6 Endothelial Growth Factors Phase 4
7 Ophthalmic Solutions Phase 2
8 Pharmaceutical Solutions Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 The Role of Unilateral Intravitreal Bevacizumab (Avastin), for the Treatment of Bilateral Diabetic Macular Edema: a Pilot Study. Completed NCT00496405 Phase 4 bevacizumab
2 An Open-label, Phase 2a Study to Evaluate Pazopanib Eye Drops Administered for 12 Weeks to Patients With Neovascular Age-related Macular Degeneration Terminated NCT01362348 Phase 2 pazopanib eye drops

Search NIH Clinical Center for Macular Degeneration, Age-Related, 10

Genetic Tests for Macular Degeneration, Age-Related, 10

Genetic tests related to Macular Degeneration, Age-Related, 10:

# Genetic test Affiliating Genes
1 Age-Related Macular Degeneration 10 29

Anatomical Context for Macular Degeneration, Age-Related, 10

MalaCards organs/tissues related to Macular Degeneration, Age-Related, 10:

41
Eye, Endothelial

Publications for Macular Degeneration, Age-Related, 10

Articles related to Macular Degeneration, Age-Related, 10:

# Title Authors PMID Year
1
Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. 8
15829498 2005
2
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. 8
14691731 2004
3
Age-related macular degeneration--a genome scan in extended families. 8
12900797 2003
4
Reliability of colour perimetry to assess macular pigment optical density in age-related macular degeneration. 38
31422700 2019
5
[Age-related macular degeneration: 10 key messages]. 38
30512452 2017
6
European survey on the opinion and use of micronutrition in age-related macular degeneration: 10 years on from the Age-Related Eye Disease Study. 38
25336904 2014
7
Five year incidence of visual field loss in adult Chinese. The Beijing Eye Study. 38
22624000 2012
8
Vision loss in Australia. 38
15938683 2005
9
Change in full-field ERGs after macular translocation surgery with 360 degrees retinotomy. 38
11818390 2002
10
Epidemiological aspects of visual impairment above 50 years in a rural area. 38
7890940 1994

Variations for Macular Degeneration, Age-Related, 10

Expression for Macular Degeneration, Age-Related, 10

Search GEO for disease gene expression data for Macular Degeneration, Age-Related, 10.

Pathways for Macular Degeneration, Age-Related, 10

GO Terms for Macular Degeneration, Age-Related, 10

Sources for Macular Degeneration, Age-Related, 10

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....